Yunis–Varon syndrome

From WikiMD's WELLNESSPEDIA

(Redirected from Yunis-Varon syndrome)

Yunis–Varon syndrome
Synonyms YVS
Pronounce N/A
Specialty N/A
Symptoms N/A
Complications N/A
Onset N/A
Duration N/A
Types N/A
Causes N/A
Risks N/A
Diagnosis N/A
Differential diagnosis N/A
Prevention N/A
Treatment N/A
Medication N/A
Prognosis N/A
Frequency N/A
Deaths N/A


Yunis–Varon syndrome (YVS) is a rare genetic disorder characterized by skeletal abnormalities, craniofacial dysmorphism, and ectodermal dysplasia. It is an autosomal recessive condition, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.

Signs and Symptoms[edit]

Individuals with Yunis–Varon syndrome typically present with a range of clinical features, which may include:

Genetics[edit]

Yunis–Varon syndrome is caused by mutations in the FIG4 gene, which is located on chromosome 6. The FIG4 gene is involved in the regulation of phosphoinositides, which are important for cell membrane dynamics and intracellular signaling.

Diagnosis[edit]

Diagnosis of Yunis–Varon syndrome is based on clinical evaluation and the identification of characteristic features. Genetic testing can confirm the diagnosis by identifying mutations in the FIG4 gene. Prenatal diagnosis is possible if the mutations in the family are known.

Management[edit]

There is no cure for Yunis–Varon syndrome, and treatment is primarily supportive. Management may include:

Prognosis[edit]

The prognosis for individuals with Yunis–Varon syndrome varies depending on the severity of the symptoms. Some individuals may have a relatively mild form of the disorder, while others may experience significant health challenges.

Epidemiology[edit]

Yunis–Varon syndrome is extremely rare, with only a few dozen cases reported in the medical literature. It affects both males and females equally.

See Also[edit]

External Links[edit]

NIH genetic and rare disease info[edit]

Yunis–Varon syndrome is a rare disease.


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.